-
FDA: Lilly Weight-Loss Drug Shortage Resolved
The U.S. Food and Drug Administration said on Thursday that Eli Lilly's weight-loss drug shortage has been resolved, following a re-evaluation of the drug's supply by the agency. Still, the FDA said it would not take any action against compounding pharmacies making cheaper...
-
Novo Responds to Ozempic's Link to Rare Eye Disease
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular diabetes drug Ozempic to a rare sight-threatening eye condition. The two studies conducted by University of...
-
Common Blood Test Could Spot Multiple Diseases
A blood draw is a typical part of a person's regular check-up. But that blood sample might hold a lot more useful information about a person's health than doctors are currently getting. A new study shows that a routine part of a blood test called the complete blood count...
-
Half of Calories Eaten at Home are Ultra-Processed
Unhealthy ultra-processed foods have wormed their way into American kitchens, likely harming people's health for decades, a new study warns. More than half of the calories adults eat at home now come from ultra-processed foods, which contain high levels of sugar, salt, fat...
-
Dark Chocolate Lowers Risk for Type 2 Diabetes
The choice may be bittersweet, but the evidence is clear: New research shows that dark chocolate can lower a person's risk of Type 2 diabetes. People who ate at least five servings of dark chocolate a week had a 21% lower risk of the blood sugar disease, researchers found....
-
Dr. Crandall: Drink Coffee for a Healthier Heart
It seems like the news on whether drinking coffee is detrimental, or beneficial, to our health flip flops all the time. But now a new study brings good news to those of us who like to enjoy a hot cup of coffee, or three. Drinking coffee can help protect against heart...
-
6 Promising Health Benefits of Weight Loss Drugs
Weight loss drugs, including Ozempic, can help people lose about 15% of their body weight. Semaglutide, the generic name for Wegovy and Ozempic, was designed to treat diabetes, but was found to be help obese men and women shed unwanted pounds. And now, doctors are finding...
-
Study: Zepbound Improves Heart Failure Symptoms
A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows.The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed for two...
-
Diabetes Diagnosis Before 50 Raises Dementia Risk
A Type 2 diabetes diagnosis before age 50 comes with a health risk that patients might not expect. Especially if they are obese, these folks are more likely to develop dementia later, new research warns. "Our study suggests that there may be a cognitive consequences to...
-
Half of Americans May Be Candidates for Ozempic
More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for treating diabetes and Wegovy to spur weight loss, the medication could be indicated for those two...
-
Diabetes Cases Have Doubled: Protect Yourself
Diabetes rates have doubled worldwide in the last 30 years, according to new statistics published this week in The Lancet journal. The study authors note that this is the first global analysis of the number of diabetes cases and treatment rates that includes all...
-
How GLP-1 Weight Loss Meds Curb Alcohol Abuse
There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to curb problem drinking. Now, a new study out of Britain adds to that growing pile of evidence. "Our findings show that...
-
Lilly Weight-Loss Drug Keeps Patients Diabetes-Free
Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of weekly injections. The results suggest that tirzepatide - the active ingredient in Lilly's diabetes drug Mounjaro and weight-loss treatment Zepbound -...
-
Diabetes Rates Have Doubled Worldwide in 30 Years
Fourteen percent of the world's people - more than 800 million - now have diabetes, a doubling of the global rate for the blood sugar disease since 1990, new statistics show. Type 2 diabetes, which makes up 95% of cases, is surging in poorer countries. However, across these...
-
US Diabetes Rates Rise to Nearly 1 in 6 Adults
Nearly 16% of American adults - that's close to 1 in 6 - now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention. Increasing age and widening waistlines greatly increase the odds for the disease, which happens when the body...
-
Medicaid Covers GLP-1 Obesity Meds in Just 13 States
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under...
-
More Hot Flashes Linked to Higher Diabetes Risk
Menopausal women with frequent hot flashes and night sweats are more likely to develop Type 2 diabetes, a new study warns. Middle-aged women who regularly suffer those well-known symptoms of menopause are 50% more likely to wind up with Type 2 diabetes, researchers reported...
-
Trial Finds Wegovy Improves Liver Fibrosis
Novo Nordisk said on Friday its weight-loss drug met the main goal of a late-stage trial by showing improvement in liver fibrosis with no worsening of steatohepatitis. The trial, which studied 2.4 milligram dose of semaglutide, showed a statistically significant improvement...
-
Pumpkin Packs a Powerful Nutritional Punch
They're everywhere! Pumpkins are on display in every shape and color in supermarkets across the country. While carving them is lots of fun for the family this Halloween, eating this fruit bestows a myriad of important health benefits. According to Rebecca Kastin, a graduate...
-
Eye Color is Linked to Health, Personality Traits
There is a saying, most often attributed to Shakespeare, that "the eyes are the window to the soul," and research now finds that eye color also provides clues about our health and personality traits. According to WebMD, here are some examples: Macular degeneration....
-
Ozempic May Lower Alzheimer's Risk With Diabetes
Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says. People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients...
-
Reducing Carbs Improves Diabetes Patients' Health
Type 2 diabetes is caused in part by the failure of pancreatic beta cells to respond as they should to blood sugar. Now, new research suggests that switching to a low-carbohydrate diet might correct that beta cell dysfunction, boosting patients' health. "People with Type 2...
-
Oral Diabetes Drug Cuts Heart Risks by 14 Percent
Novo Nordisk said on Monday an oral version of its drug semaglutide, helped significantly reduce the risk of cardiovascular events in patients in a late-stage study. The drug, Rybelsus, helped reduce the risk of these events, including cardiovascular death, non-fatal heart...
-
GLP-1 Weight Loss Meds Effective Against Alcoholism
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds. People taking this class of drugs, called glucagon-like peptide-1 receptor agonists (GLP-1), have a 50% lower rate of...
-
Taking Metformin Safe for Men's Offspring
Men can take the widely prescribed diabetes drug metformin without fear of causing birth defects in their children, according to results of a large study published on Wednesday. Tracking more than 3 million pregnancies in Norway and Taiwan, researchers found no association...